Cite Filings / ALKS / 0001964306-26-000196
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Alkermes plc. · Filed 2026-04-01 · Acc 0001964306-26-000196

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-04-06 144 Sale of Securities
  • 2026-04-06 ARS Annual Report to Security Holders
  • 2026-04-06 DEFA14A Proxy Materials
  • 2026-04-01 144 Sale of Securities
  • 2026-04-01 4 EVP R&D, Chief Medical Officer sold 9,000 shares at $35.51 ($319,604)
  • 2026-03-27 PRE 14A Proxy Statement (Preliminary)
  • 2026-03-03 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…